체성분 분석기 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 최종 용도별, 지역별, 부문 예측(2025-2033년)

Body Composition Analyzers Market Summary

The global body composition analyzers market size was estimated at USD 714.2 million in 2024 and is projected to reach USD 1,261.6 million by 2033, growing at a CAGR of 6.4% from 2025 to 2033. This growth is driven by rising awareness of obesity and chronic diseases, increasing fitness and wellness trends, and growing adoption of preventive healthcare.

Technological advancements, including portable and user-friendly devices, further fuel demand. In addition, rising investments in sports science, workplace wellness programs, and healthcare infrastructure support market expansion.

The global body composition analyzers industry is experiencing rapid growth, driven by rising obesity rates, increasing metabolic disorders, and heightened consumer health awareness. Obesity is projected to affect 1.13 billion adults by 2030, while in 2024, 506 million people are reported to have metabolic disorders. Traditional metrics like BMI often fail to detect sarcopenic obesity, where high fat and low muscle mass coexist. As a result, clinical guidelines increasingly favor impedance-based body composition analysis, which offers a more precise assessment of fat, muscle, visceral adiposity, and hydration levels. This shift is transforming analyzers from optional tools into essential devices in both preventative and clinical care, making them a core segment of the healthcare diagnostic market.

Healthcare systems and insurers are further fueling market expansion. Payer incentives now reward early risk stratification, as detecting metabolic deterioration early reduces long-term treatment costs. Hospitals and clinics are incorporating body composition analyzers into annual wellness programs, bariatric surgery pathways, and malnutrition screening protocols. For example, the 2025 U.S. Physician Fee Schedule reimburses impedance-based muscle-mass assessments, while European payers increasingly cover sarcopenia diagnostics following the Global Leadership Initiative on Malnutrition. This policy develops lower barriers for small clinics and primary care offices, expanding the market beyond large hospitals. Corporate wellness programs also subsidize onsite scans, further enlarging the reimbursed user base. In Asia Pacific, broader adoption is expected as pilot studies demonstrate reductions in diabetes- and cardiovascular-related expenditures, indicating future regional growth potential.

Government initiatives further bolster the adoption of body composition analyzers. For instance, the All-India Institute of Medical Sciences (AIIMS) in New Delhi procured a body composition analyzer through the Government e-Marketplace (GeM) in early 2024, indicating the government's commitment to integrating advanced diagnostic tools in public healthcare institutions

Consumer-driven demand is equally significant. Awareness of lean mass preservation and healthy aging has risen, with social media highlighting the "skinny-fat" phenomenon. Fitness enthusiasts, athletes, and gym members now prioritize tracking fat percentage, hydration, and visceral fat over simple weight. Retailers report double-digit growth in connected scales, while health apps integrate impedance results with diet and exercise plans. Devices like the Hume Health Body Pod, launched in September 2025, exemplify this trend. Using multi-frequency bioelectrical impedance analysis, the Body Pod provides over 40 health metrics, including body fat, skeletal muscle, total body water, visceral fat index, and basal metabolic rate. Segmental analysis allows users to track specific regions, arms, legs, and trunks, offering actionable insights for training, recovery, and long-term health trends. Its home-based, non-invasive design makes it accessible, bridging the consumer and clinical segments of the market.

Global Body Composition Analyzers Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global body composition analyzers market report based on product, end-use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Calipers
• Bioimpedance Analyzers
• Hydrostatic Weighing
• DEXA (Dual-Energy X-Ray Absorptiometry)
• Air-Displacement Plethysmography
• Others
• End-use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals & Clinics
• Fitness Centers and Gymnasiums
• Homecare Center
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. End Use
  • 1.2.3. Regional scope
  • 1.2.4. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. End use outlook
  • 2.2.3. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Body Composition Analyzers Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. Body Composition Analyzers Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Body Composition Analyzers Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Body Composition Analyzers Product Market Movement Analysis
• 4.3. Global Body Composition Analyzers Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
• 4.4. Calipers
  • 4.4.1. Calipers market estimates and forecasts 2021 to 2033 (USD Million)
• 4.5. Bioimpedance Analyzers
  • 4.5.1. Bioimpedance analyzers market estimates and forecasts 2021 to 2033 (USD Million)
• 4.6. Hydrostatic Weighing
  • 4.6.1. Hydrostatic Weighing market estimates and forecasts 2021 to 2033 (USD Million)
• 4.7. DEXA (Dual-Energy X-Ray Absorptiometry)
  • 4.7.1. DEXA (Dual-Energy X-Ray Absorptiometry) market estimates and forecasts 2021 to 2033 (USD Million)
• 4.8. Air-Displacement Plethysmography
  • 4.8.1. Air-Displacement Plethysmography market estimates and forecasts 2021 to 2033 (USD Million)
• 4.9. Others
  • 4.9.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Body Composition Analyzers Market: End Use Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Body Composition Analyzers End Use Market Movement Analysis
• 5.3. Global Body Composition Analyzers Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 5.4. Hospitals & Clinics
  • 5.4.1. Hospitals & Clinics market estimates and forecasts 2021 to 2033 (USD Million)
• 5.5. Fitness Centers and Gymnasiums
  • 5.5.1. Fitness Centers and Gymnasiums market estimates and forecasts 2021 to 2033 (USD Million)
• 5.6. Homecare Center
  • 5.6.1. Homecare Center market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Body Composition Analyzers Market: Regional Estimates & Trend Analysis By Product, End Use

• 6.1. Regional Market Share Analysis, 2025 & 2033
• 6.2. Regional Market Dashboard
• 6.3. Global Regional Market Snapshot
• 6.4. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
• 6.5. North America
  • 6.5.1. U.S.
    • 6.5.1.1. Key country dynamics
    • 6.5.1.2. Competitive scenario
    • 6.5.1.3. Regulatory framework
    • 6.5.1.4. Reimbursement structure
    • 6.5.1.5. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5.2. Canada
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. Competitive scenario
    • 6.5.2.3. Regulatory framework
    • 6.5.2.4. Reimbursement structure
    • 6.5.2.5. Canada market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5.3. Mexico
    • 6.5.3.1. Key country dynamics
    • 6.5.3.2. Competitive scenario
    • 6.5.3.3. Regulatory framework
    • 6.5.3.4. Reimbursement structure
    • 6.5.3.5. Canada market estimates and forecasts 2021 to 2033 (USD Million)
• 6.6. Europe
  • 6.6.1. UK
    • 6.6.1.1. Key country dynamics
    • 6.6.1.2. Competitive scenario
    • 6.6.1.3. Regulatory framework
    • 6.6.1.4. Reimbursement structure
    • 6.6.1.5. UK market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6.2. Germany
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Competitive scenario
    • 6.6.2.3. Regulatory framework
    • 6.6.2.4. Reimbursement structure
    • 6.6.2.5. Germany market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6.3. France
    • 6.6.3.1. Key country dynamics
    • 6.6.3.2. Competitive scenario
    • 6.6.3.3. Regulatory framework
    • 6.6.3.4. Reimbursement structure
    • 6.6.3.5. France market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6.4. Italy
    • 6.6.4.1. Key country dynamics
    • 6.6.4.2. Competitive scenario
    • 6.6.4.3. Regulatory framework
    • 6.6.4.4. Reimbursement structure
    • 6.6.4.5. Italy market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6.5. Spain
    • 6.6.5.1. Key country dynamics
    • 6.6.5.2. Competitive scenario
    • 6.6.5.3. Regulatory framework
    • 6.6.5.4. Reimbursement structure
    • 6.6.5.5. Spain market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6.6. Norway
    • 6.6.6.1. Key country dynamics
    • 6.6.6.2. Competitive scenario
    • 6.6.6.3. Regulatory framework
    • 6.6.6.4. Reimbursement structure
    • 6.6.6.5. Norway market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6.7. Sweden
    • 6.6.7.1. Key country dynamics
    • 6.6.7.2. Competitive scenario
    • 6.6.7.3. Regulatory framework
    • 6.6.7.4. Reimbursement structure
    • 6.6.7.5. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6.8. Denmark
    • 6.6.8.1. Key country dynamics
    • 6.6.8.2. Competitive scenario
    • 6.6.8.3. Regulatory framework
    • 6.6.8.4. Reimbursement structure
    • 6.6.8.5. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
• 6.7. Asia Pacific
  • 6.7.1. Japan
    • 6.7.1.1. Key country dynamics
    • 6.7.1.2. Competitive scenario
    • 6.7.1.3. Regulatory framework
    • 6.7.1.4. Reimbursement structure
    • 6.7.1.5. Japan market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7.2. China
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Competitive scenario
    • 6.7.2.3. Regulatory framework
    • 6.7.2.4. Reimbursement structure
    • 6.7.2.5. China market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7.3. India
    • 6.7.3.1. Key country dynamics
    • 6.7.3.2. Competitive scenario
    • 6.7.3.3. Regulatory framework
    • 6.7.3.4. Reimbursement structure
    • 6.7.3.5. India market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7.4. Australia
    • 6.7.4.1. Key country dynamics
    • 6.7.4.2. Competitive scenario
    • 6.7.4.3. Regulatory framework
    • 6.7.4.4. Reimbursement structure
    • 6.7.4.5. Australia market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7.5. South Korea
    • 6.7.5.1. Key country dynamics
    • 6.7.5.2. Competitive scenario
    • 6.7.5.3. Regulatory framework
    • 6.7.5.4. Reimbursement structure
    • 6.7.5.5. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7.6. Thailand
    • 6.7.6.1. Key country dynamics
    • 6.7.6.2. Competitive scenario
    • 6.7.6.3. Regulatory framework
    • 6.7.6.4. Reimbursement structure
    • 6.7.6.5. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
• 6.8. Latin America
  • 6.8.1. Brazil
    • 6.8.1.1. Key country dynamics
    • 6.8.1.2. Competitive scenario
    • 6.8.1.3. Regulatory framework
    • 6.8.1.4. Reimbursement structure
    • 6.8.1.5. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.8.2. Argentina
    • 6.8.2.1. Key country dynamics
    • 6.8.2.2. Competitive scenario
    • 6.8.2.3. Regulatory framework
    • 6.8.2.4. Reimbursement structure
    • 6.8.2.5. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
• 6.9. MEA
  • 6.9.1. South Africa
    • 6.9.1.1. Key country dynamics
    • 6.9.1.2. Competitive scenario
    • 6.9.1.3. Regulatory framework
    • 6.9.1.4. Reimbursement structure
    • 6.9.1.5. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.9.2. Saudi Arabia
    • 6.9.2.1. Key country dynamics
    • 6.9.2.2. Competitive scenario
    • 6.9.2.3. Regulatory framework
    • 6.9.2.4. Reimbursement structure
    • 6.9.2.5. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.9.3. UAE
    • 6.9.3.1. Key country dynamics
    • 6.9.3.2. Competitive scenario
    • 6.9.3.3. Regulatory framework
    • 6.9.3.4. Reimbursement structure
    • 6.9.3.5. UAE market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.9.4. Kuwait
    • 6.9.4.1. Key country dynamics
    • 6.9.4.2. Competitive scenario
    • 6.9.4.3. Regulatory framework
    • 6.9.4.4. Reimbursement structure
    • 6.9.4.5. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
• 7.3. Key company market share analysis, 2025
• 7.4. Company Position Analysis
• 7.5. Company Categorization (Emerging Players, Innovators and Leaders)
• 7.6. Company Profiles
  • 7.6.1. Hologic Inc.
    • 7.6.1.1. Company overview
    • 7.6.1.2. Financial performance
    • 7.6.1.3. Product benchmarking
    • 7.6.1.4. Strategic initiatives
  • 7.6.2. Bodystat Ltd
    • 7.6.2.1. Company overview
    • 7.6.2.2. Financial performance
    • 7.6.2.3. Product benchmarking
    • 7.6.2.4. Strategic initiatives
  • 7.6.3. COSMED Srl
    • 7.6.3.1. Company overview
    • 7.6.3.2. Financial performance
    • 7.6.3.3. Product benchmarking
    • 7.6.3.4. Strategic initiatives
  • 7.6.4. Charder Electronic Co. Ltd
    • 7.6.4.1. Company overview
    • 7.6.4.2. Financial performance
    • 7.6.4.3. Product benchmarking
    • 7.6.4.4. Strategic initiatives
  • 7.6.5. InBody Co. Ltd
    • 7.6.5.1. Company overview
    • 7.6.5.2. Financial performance
    • 7.6.5.3. Product benchmarking
    • 7.6.5.4. Strategic initiatives
  • 7.6.6. GE Healthcare
    • 7.6.6.1. Company overview
    • 7.6.6.2. Financial performance
    • 7.6.6.3. Product benchmarking
    • 7.6.6.4. Strategic initiatives
  • 7.6.7. Tanita Corporation
    • 7.6.7.1. Company overview
    • 7.6.7.2. Financial performance
    • 7.6.7.3. Product benchmarking
    • 7.6.7.4. Strategic initiatives
  • 7.6.8. Omron Corporation
    • 7.6.8.1. Company overview
    • 7.6.8.2. Financial performance
    • 7.6.8.3. Product benchmarking
    • 7.6.8.4. Strategic initiatives
  • 7.6.9. Seca GmbH
    • 7.6.9.1. Company overview
    • 7.6.9.2. Financial performance
    • 7.6.9.3. Product benchmarking
    • 7.6.9.4. Strategic initiatives
  • 7.6.10. Maltron International
    • 7.6.10.1. Company overview
    • 7.6.10.2. Financial performance
    • 7.6.10.3. Product benchmarking
    • 7.6.10.4. Strategic initiatives